How many patients affected by Crohn’s disease or ulcerative colitis not treated with biologic agents could be eligible for these therapies in Italy?

The BIOS21 Virtual summit is no longer accessible; stay tuned for the BIOS22 Virtual summit programme

https://www.medicinesforeurope.com/events/